Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
34.05
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Kobayashi Pharmaceutical Accounts Payable (Quarterly) : 66.67M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 66.67M |
| December 31, 2025 | 95.05M |
| September 30, 2025 | 101.70M |
| June 30, 2025 | 106.66M |
| March 31, 2025 | 101.30M |
| December 31, 2024 | 93.46M |
| September 30, 2024 | 96.94M |
| June 30, 2024 | 93.65M |
| March 31, 2024 | 110.62M |
| December 31, 2023 | 122.75M |
| September 30, 2023 | 131.14M |
| June 30, 2023 | 140.37M |
| March 31, 2023 | 139.55M |
| December 31, 2022 | 136.84M |
| September 30, 2022 | 121.66M |
| June 30, 2022 | 124.55M |
| March 31, 2022 | 131.49M |
| December 31, 2021 | 151.48M |
| September 30, 2021 | 146.81M |
| June 30, 2021 | 141.81M |
| March 31, 2021 | 136.14M |
| December 31, 2020 | 154.25M |
| September 30, 2020 | 149.17M |
| June 30, 2020 | 145.77M |
| March 31, 2020 | 144.87M |
| Date | Value |
|---|---|
| December 31, 2019 | 154.73M |
| September 30, 2019 | 166.04M |
| June 30, 2019 | 166.35M |
| March 31, 2019 | 152.78M |
| December 31, 2018 | 162.02M |
| September 30, 2018 | 158.15M |
| June 30, 2018 | 152.07M |
| March 31, 2018 | 152.42M |
| December 31, 2017 | 155.35M |
| September 30, 2017 | 159.04M |
| June 30, 2017 | 146.87M |
| March 31, 2017 | 139.47M |
| December 31, 2016 | 137.33M |
| September 30, 2016 | 161.89M |
| June 30, 2016 | 154.70M |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 112.75M |
| December 31, 2014 | 112.27M |
| September 30, 2014 | 114.44M |
| June 30, 2014 | 117.18M |
| March 31, 2014 | 110.38M |
| December 31, 2013 | 117.51M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Medifast, Inc. | 38.26M |
| Integrated BioPharma, Inc. | 2.965M |
| Kao Corp. | 1.647B |
| Shiseido Co., Ltd. | 842.61M |
| Skinvisible, Inc. | 1.355M |